Lv1
38 积分 2025-07-21 加入
A phase 1 single and multiple ascending dose study of orforglipron in Japanese participants with type 2 diabetes
8天前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
8天前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
8天前
已完结
The endocrine function of adipose tissues in health and cardiometabolic disease
1个月前
已完结
Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation
1个月前
已完结
Hormonal regulation of human adipose tissue lipolysis: impact of adipose GIP system in overweight and obesity
1个月前
已完结
Development of Recombinant High-Density Lipoprotein Platform with Innate Adipose Tissue-Targeting Abilities for Regional Fat Reduction
1个月前
已完结
Chondroitin Sulfate-Derived Micelles for Adipose Tissue-Targeted Delivery of Celastrol and Phenformin to Enhance Obesity Treatment
1个月前
已完结
Obesity pharmacotherapy: incretin action in the central nervous system
1个月前
已完结
MiR-200b-3p Inhibits Adipose Browning by Targeting Prdm16
1个月前
已关闭
皖公网安备34019202002308
